AVELLINO NEWS

Stay up to date with the latest Avellino news featuring global updates on innovative genetic diagnostics, gene therapy, and precision medicine.

04

20

2022

04/20/2022

Globally Recognized Scientific Policy and Genomics Expert Genya Dana, Ph.D. Joins Avellino as Global Head of Health Policy

Dana’s abundance of policy experience in genomics and biotechnology will help lead Avellino’s next chapter of growth as the company continues to develop its powerful data-centric diagnostic and therapeutic solutions in healthcare.

read more

03

24

2022

03/24/2022

City of Hayward, Avellino Lab Mark Two-Year Anniversary of Leadership in Covid-19 Testing

Avellino, one of California’s largest Covid-19 test providers, and the Hayward Fire Department celebrated the two-year anniversary of their joint effort opening the first free, community hosted Covid-19 drive-through testing site, which opened on March 23, 2020 in Hayward, Calif. The commemoration included a Certificate of Commendation, a celebratory lunch, and a donation to the Hayward Firefighters Charitable fund.

read more

02

07

2022

02/07/2022

Avellino Adds Respiratory Syncytial Virus (RSV) Assay to its AvellinoCoV2 – Respiratory Test

Avellino has launched an expanded AvellinoCoV2 – Respiratory Test that now detects respiratory syncytial virus (RSV). The test supports an unprecedented RSV, cold and flu season complicated by the continued impact of COVID-19 and the ‘flurona’ infection.

read more

02

02

2022

02/02/2022

Omicron Surge Prompts Opening of New Drive-Through Community Covid Testing Site by Leading Bay Area Covid Test Provider

Avellino, one of California’s largest COVID test providers, has opened a new drive-through COVID-19 testing site at its company headquarters in Menlo Park, CA to support the urgent need for greater testing access due to shortages of home tests and long testing lines elsewhere.

read more

01

18

2022

01/18/2022

Avellino Enters into Distribution Agreement With Keeler to Sell AvaGen, The Genetic Eye Test

Menlo Park, CA

Avellino and Keeler, a global ophthalmic device manufacturer and distributor, have entered into an agreement where Keeler will distribute AvaGen on its US website. AvaGen is the first genetic test that helps determine a patient’s risk of keratoconus and the presence of TGFBI corneal dystrophies.

read more

01

05

2022

01/05/2022

Nationally Recognized Ophthalmologist Dr. Elizabeth Yeu Joins Avellino’s Board of Directors

Menlo Park, CA

Dr. Yeu’s depth of experience will help Avellino as the company continues to provide genetic-based diagnostics for the ophthalmic industry and expands its innovative product pipeline to new disease areas such as glaucoma.

read more

11

16

2021

11/16/2021

Avellino Appoints Jon Robson as CEO and Member of the Board of Directors

Menlo Park, California

Avellino Lab USA, Inc. (Avellino) is pleased to announce Jon Robson as the company’s new CEO and member of the Board of Directors. Jon will lead the company’s next phase of innovation and growth, including further integrating Avellino’s depth of genetic expertise with machine learning, AI, and big data. This impactful combination will help the company continue to develop life-changing diagnostics and therapeutics that help improve patient outcomes, along with curating a diverse genetic database.

read more

11

02

2021

11/02/2021

Avellino Donates $25,000 to National Keratoconus Foundation to Support World Keratoconus Day and Disease Education

Menlo Park, California

Avellino Lab USA, Inc. (Avellino), in honor of World Keratoconus Day, today announced a $25,000 donation to the National Keratoconus Foundation (NKCF) to support their educational efforts for this sight-threatening disease. Keratoconus is a genetic eye disease that changes the cornea, distorting the front of the eye into a cone shape. It can affect both eyes, and without treatment, vision can progressively deteriorate.

read more

08

03

2021

08/03/2021

Former World Economic Forum Member of the Managing Board Murat Sönmez Joins Avellino’s Board of Directors

Menlo Park, California

Avellino Lab USA, Inc. (Avellino) today announced the appointment of Murat Sönmez to the company’s Board of Directors. Murat is a former World Economic Forum Member of the Managing Board and founding head of their Centre for the Fourth Industrial Revolution, a public-private partnership institution he established in 2017 to help accelerate the benefits of science and technology among nations and organizations.

His depth of experience in digital technology, technology policy and global business will help guide Avellino as it continues to provide genetic-based diagnostics and eventual therapeutics and genetic data licensing to both the global medical and scientific community.

read more

07

07

2021

07/07/2021

Avellino Partners with Sugentech, Inc. to Distribute SGTi-flex COVID-19 IgG Antibody Test

Menlo Park, California

Avellino and Sugentech, Inc., a bio- and nano- based technology and in-vitro diagnostic firm based in Korea, as part of their partnership agreement announced in August 2020, has begun distribution of Sugentech’s SGTi-flex COVID-19 IgG antibody test in the US. Sugentech received FDA Emergency Use Authorization (EUA) for the SGTi-flex COVID-19 IgG antibody test in April 2021.

read more

06

28

2021

06/28/2021

Avellino Surpasses Two Million COVID-19 Tests in United States

Menlo Park, California

Avellino today announced that more than two million of its SARS-CoV-2/COVID-19 Tests (AvellinoCoV2) have now been performed in the United States.

Avellino was one of the first private companies in the U.S. to receive an Emergency Use Authorization (EUA) from the FDA for AvellinoCoV2 in March 2020. The test provided much-needed testing capacity during the initial surge of the pandemic in the U.S., in particular among populations in skilled nursing facilities, schools, colleges and government municipalities.

read more

06

02

2021

06/02/2021

Avellino Launches AvaGenTM Nationwide as the First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal Dystrophies

Menlo Park, California

Avellino today announced full nationwide availability in the U.S. of AvaGen™, The Genetic Eye Test, as the first genetic test that helps determine a patient’s risk of keratoconus and the presence of other corneal dystrophies. The test allows for more confident management and treatment for patients with these conditions in order to protect and preserve patient vision.

read more

05

20

2021

05/20/2021

Laiq Ahmad Joins Avellino Labs as Chief Technology Officer

Menlo Park, California

Ahmad brings more than 22 years of experience to the role, with advanced knowledge of digital transformation, cloud technologies, big data, AI, and machine learning. In this role he will be leading technology, engineering and the innovation engine for the company’s next-generation sequencing applications and platforms, drive technology breakthroughs, and support Avellino Labs’ growth and innovation.

read more

12

12

2020

12/12/2020

Avellino Expands its Board of Directors and Welcomes New Executive Management Members

Menlo Park, California

Avellino announced today the appointment of three new members to its Board of Directors.

read more

11

09

2020

11/09/2020

Avellino Introduces New Multiplex Respiratory Panel

Menlo Park, California

Avellino announced today that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which has been validated following the U.S. Food and Drug Adminiistration’s Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing CLIA guidelines.

read more

08

25

2020

08/25/2020

Avellino and Sugentech Announce Strategic Collaboration

Menlo Park, California

Partnership Focused In Short Term On COVID-19 Genetic Diagnostics and Solutions, Long Term Collaboration On Partner Diagnostics and Therapeutics

read more

08

13

2020

08/13/2020

Avellino Hits the 1-Million Genetic Test Milestone

Menlo Park, California

On track for over 10,000 gene-based diagnostic tests performed a day.

read more

03

26

2020

03/26/2020

Bay Area Lab Aims to Distribute Millions of Coronavirus Test After Creating Their Own

NBC Bay Area

The NBC Bay Area Investigative Unit was granted exclusive access inside Avellino Laboratory, a Menlo Park-based genetic research firm that designed its own test for COVID-19. The lab plans to soon triple its staff in order to bolster its processing capacity to at least 7,000 coronavirus tests per day – potentially totaling millions of tests over the next year.

read more

03

11

2020

03/11/2020

Avellino’s Coronavirus test now available, FDA approval pending

BioWorld

Avellino Lab USA Inc. has developed a diagnostic test for the novel coronavirus SARS-CoV-2, which has been validated in keeping with the U.S. Food and Drug Administration (FDA)’s Policy for Diagnostics Testing in Laboratories Certified to Perform High-Complexity Testing under CLIA prior to Emergency Use Authorization for Coronavirus Disease-2019 during the Public Health Emergency.

read more

10

14

2019

10/14/2019

Avellino Labs Receives CLIA Certification For AvaGen

Menlo Park, California

Avellino Labs is proud to announce that it has received CLIA certification for AvaGen, a genetic diagnostic test for keratoconus and corneal dystrophies. With the certification, Avellino Labs can begin rolling out the availability of AvaGen nationwide.

read more

05

23

2019

05/23/2019

Prominent Technologist William (Bill) F. Stasior Joins Avellino Labs Executive Advisory Committee

Menlo Park, California

Avellino Labs announced the addition of William F. Stasior to the company’s Executive Advisory Committee and consultant to the company. Mr Stasior will advance Avellino Labs genetic data management infrastructure to support the company’s growth and expanding application of its technology in health and precision medicine.

read more

04

29

2019

04/29/2019

Avellino Labs Expands Medical Advisory Board With Internationally Renowned Ophthalmologists

Menlo Park, California

Avellino Labs, global biotechnology and genetic science innovators, announced that Eric Donnenfeld, MD; Edward Holland, MD; Richard Lindstrom, MD; and Elizabeth Yeu, MD have joined its board of medical advisors. These additions confirm Avellino Labs’ strong commitment to the future of diagnostics and therapeutic treatments for the cornea.

read more

04

16

2019

04/16/2019

Eric Bernabei Joins Avellino Labs as Chief Sales and Marketing Officer

Menlo Park, California

Avellino Labs, global biotechnology and genetic science innovators, announced Eric Bernabei as the company’s chief sales and marketing officer (CSMO). The addition of Bernabei will further extend Avellino Labs’ leadership in global genetics and ophthalmic communities. Bernabei joins Avellino Labs with more than 20 years of product development and commercialization experience in ophthalmology.

read more

Explore More

Explore_Icon.png